Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on protection free synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve NMR imaging agent supply chain risks with this patent-validated synthesis. 92-96% yields, no toxic reagents, and 75%+ step recovery. Scale to 100MT/yr.
Solve Delgocitinib manufacturing challenges with novel 6-step synthesis. Eliminate protection/deprotection steps, reduce costs by 30%. Contact for scalable production.